-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - applicability to clinical practice, paying special
attention to study eligibility criteria, demographic features
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - population characteristics (e.g. age, gender, race, ethnicity, and severity of asthma),
and intervention features
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
January 01, 2010 - summary is excellent, so readers have a choice
whether to explore the detail or read the salient
features
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - characteristics (age, gender, race, ethnicity, duration and severity of
diabetes), and intervention features
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
July 29, 2014 - Electronic Health Records
(EHRs) incorporate many features, including documentation of all
of a patient
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
November 27, 2012 - We
expanded on eligibility and study design features that limit
the applicability to broad populations
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - Given the unique features of this study and the
importance of its findings to the systematic review,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
January 01, 2009 - 13-MDM347013 30..38
Medical Tests—White Paper Series
Additional Patient Outcomes and Pathways in
Evaluations of Testing
The findings and conclusions in this document are those of the authors, who are responsible for its
contents; the findings and conclusions do not necessarily represent the views…
-
effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
October 01, 2007 - ORIGINAL ARTICLE
Designed Delays Versus Rigorous Pragmatic Trials
Lower Carat Gold Standards Can Produce Relevant Drug Evaluations
Malcolm Maclure, ScD,* Bruce Carleton, PharmD,† and Sebastian Schneeweiss, MD, ScD‡§¶
Background: Centralized administrative databases enable low-cost
pragmatic randomized trials (PRTs) …